A. Brattström

Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.

Stefan Peters, Bert Götting, Martina Trümmel et al. · PubMed · 2001 · 132 citations

Endovascular Technique, Chronic Administration, Surgery +18

Identification and Isolation of the Cyclooxygenase-2 Inhibitory Principle in Isatis tinctoria

Henning Danz, Stefka Stoyanova, Petra Wippich et al. · Planta Medica · 2001 · 121 citations

Dermatology, Chemical Biology, Cox-2 Inhibitory Principle +17

Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS)

Dave K. Berger, W. Schaffner, E. Schrader et al. · Archives of Gynecology and Obstetrics · 2000 · 108 citations

Infertility, Gynecology, Reproductive Medicine +4

In vitro binding experiments with a Valerian, Hops and their fixed combination extract (Ze91019) to selected central nervous system receptors

Ehab A. Abourashed, Uwe Koetter, A. Brattström · Phytomedicine · 2004 · 89 citations

Functional Selectivity, Medicine, Physiology +11

Interactions of valerian extracts and a fixed valerian–hop extract combination with adenosine receptors

Christa E. Müller, Britta Schumacher, A. Brattström et al. · Life Sciences · 2002 · 82 citations

Valerian Extracts, Adenosine Receptors, Biochemistry +6